How Cartilage Works—and Why It Can't Heal Itself
Cartilage is the smooth, rubbery tissue that cushions every joint in the body, yet it is one of the few tissues that cannot repair itself after damage. Understanding why—and what scientists are doing about it—matters to the 600 million people worldwide living with osteoarthritis.
Every time you bend a knee, rotate a shoulder, or turn your head, a thin layer of glistening white tissue absorbs the shock and lets bone glide against bone without friction. That tissue is articular cartilage, and it is remarkably good at its job—until it gets damaged. Once cartilage wears away, the body has almost no ability to grow it back.
This biological limitation is at the heart of osteoarthritis, the most common joint disease on the planet. According to a systematic analysis published in The Lancet Rheumatology, roughly 595 million people were living with osteoarthritis worldwide in 2020—a 132 percent increase since 1990. The number is projected to approach one billion by 2050. The knee is the most frequently affected joint, accounting for some 365 million cases.
What Cartilage Is Made Of
Articular cartilage is a specialized connective tissue composed of just one cell type: chondrocytes. These cells sit inside tiny pockets called lacunae, embedded in a dense extracellular matrix of collagen fibers and proteoglycans. The matrix gives cartilage its unique combination of strength and elasticity, allowing it to absorb compressive forces many times a person's body weight during everyday activities like walking or climbing stairs.
Cartilage is organized into distinct zones, each with a different collagen orientation. The surface zone has fibers aligned parallel to the joint, resisting shear. Deeper layers have fibers oriented vertically, resisting compression. This architecture is precisely engineered by nature—and extremely difficult to replicate.
Why It Cannot Repair Itself
Most tissues in the body heal through a well-rehearsed sequence: blood rushes to the injury site, delivering oxygen, immune cells, and growth factors that trigger repair. Cartilage skips this entire process because it has no blood vessels. It is avascular, meaning chondrocytes receive nutrients solely through slow diffusion from the synovial fluid that bathes the joint.
This creates a cascade of problems. Without blood supply, there is no inflammatory response to kick-start healing. Without inflammation, there is no recruitment of stem cells or progenitor cells to the damage site. And because chondrocytes are locked inside their lacunae within a dense matrix, they cannot migrate to fill a defect the way skin cells crawl across a wound. Cartilage also lacks lymphatic drainage and nerve supply, which further limits the body's awareness of and response to injury.
The result is that even small cartilage defects tend to persist and gradually enlarge. Mechanical stress concentrates around the edges of the defect, accelerating breakdown. Over years, the protective layer thins until bone grinds against bone—the hallmark pain of advanced osteoarthritis.
Current Treatment Options
Because cartilage cannot regenerate on its own, current treatments focus on managing symptoms rather than reversing damage. Physical therapy, weight management, and exercise strengthen the muscles around a joint and can reduce pain. Anti-inflammatory medications help control flare-ups. When conservative approaches fail, surgeons may perform microfracture—drilling tiny holes into the bone beneath the cartilage to release marrow cells—but this produces fibrocartilage, a rougher, weaker substitute that tends to break down within a few years.
For severe cases, joint replacement surgery remains the most reliable solution. Surgeons in the United States alone perform more than 790,000 knee replacements annually. Artificial joints last 15 to 20 years on average, but they are not ideal for younger, active patients who may outlive the implant.
The Race to Regrow Cartilage
Scientists are pursuing multiple strategies to overcome cartilage's biological stubbornness. One of the most promising recent breakthroughs came from Stanford Medicine, where researchers identified a protein called 15-PGDH that increases with age and suppresses cartilage regeneration. When they blocked this protein in aged mice, chondrocytes reverted to a more youthful state and began producing healthy new cartilage—without requiring stem cell transplants. Human cartilage samples from knee replacement surgeries showed early signs of regeneration after exposure to the same treatment.
Other approaches include implanting lab-grown chondrocytes derived from induced pluripotent stem cells, using bioactive scaffolds seeded with mesenchymal stem cells, and harnessing extracellular vesicles called exosomes to deliver anti-inflammatory signals directly to damaged joints. Three-dimensional bioprinting is also being explored to fabricate patient-specific cartilage constructs with the precise layered architecture that natural cartilage requires.
None of these therapies has yet reached widespread clinical use, but the pace of discovery is accelerating. For the hundreds of millions of people whose joints are quietly wearing away, the question of why cartilage cannot heal itself may soon have a more hopeful follow-up: how science learned to make it try.
